Proteasome blockers inhibit TNF-α release by lipopolysaccharide stimulated macrophages and microglia: Implications for HIV-1 dementia

Journal of Neuroimmunology

Volumn 95, Issue 1-2, 1999, Pages 55-64

  Fine, Steven M ^a   Maggirwar, Sanjay B ^b   Elliott, Paige R ^a   Epstein, Leon G ^b   Gelbard, Harris A ^b   Dewhurst, Stephen ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Human immunodeficiency virus type 1; Lipopolysaccharide; Macrophage; Microglia; NF B; Proteasome inhibitor; Tumor necrosis factor alpha

Indexed keywords

LIPOPOLYSACCHARIDE; NEUROTOXIN; PROTEASOME INHIBITOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ISOLATION; DEMENTIA; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MACROPHAGE; MICROGLIA; PRIORITY JOURNAL; VIRUS INFECTION;

AIDS DEMENTIA COMPLEX; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DNA PROBES; ENZYME ACTIVATION; FETUS; GENE EXPRESSION; HIV-1; HUMANS; LEUPEPTINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICROGLIA; MULTIENZYME COMPLEXES; NF-KAPPA B; PHAGOCYTOSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033104106     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00267-7     Document Type: Article

References (58)

1. Akassoglou K., Probert L., Kontogeorgos G., Kollias G. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158(1):1997;438-445.
2. Bacellar H., Munoz A., Miller E.M., Cohen B.A., Besley D., Selnes O.A., Becker J.T., McArthur J.C. Temporal trends in the incidence of HIV-1-related neurologic diseases; multicenter AIDS cohort study, 1985-1992. Neurology. 44(10):1994;1892-1900.
3. Baeuerly P.A., Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor for the NF-kappa B transcription factor. Cell. 53(2):1988;211-217.
4. Beg A.A., Baltimore D. An essential role for NF-kB in preventing TNF-α-induced cell death. Science. 274:1996;782-784.
5. Beg A.A., Finco T.S., Nantermet P.V., Baldwin A.S. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκB: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:1993;3301-3310.
6. Bellas R.E., Fitzgerald M.J., Fausto F., Sonenshein G.E. Inhibition of NF-κB activity induces apoptosis in murine hepatocytes. Am. J. Pathol. 151(4):1997;891-896.
7. + exchange in astrocytes. J. Biol. Chem. 269(19):1994;13811-13816.
8. Chao C.C., Hu S. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16:1994;172-179.
9. Chao C.C., Hu S., Close K., Choi C.S., Molitor T.W., Novick W.J., Peterson R.K. Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone. J. Infect. Dis. 166:1992;847-853.
10. Chen P., Mayne M., Power C., Nath A. The tat protein of HIV-1 induces tumor necrosis factor-α production. J. Biol. Chem. 272(36):1997;22385-22388.
11. Clouse K.A., Cosentino L.M., Weih K.A., Pyle S.W., Robbins P.B., Hochstein H.D., Natarajan V., Farrar W.L. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J. Immunol. 147(9):1991;2892-2901.
12. Cooper P.H., Mayer P., Baggiolini M. Stimulation of phagocytosis in bone marrow-derived mouse macrophages by bacterial lipopolysaccharide: correlation with biochemical and functional parameters. J. Immunol. 133(2):1984;913-922.
13. Cordle S.R., Donald R., Read M.A., Hawiger J. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-rel and related NF-κB proteins in human monocytic THP-1 cells. J. Biol. Chem. 268:1993;11803-11810.
14. Dewhurst S., Gelbard H.A., Fine S.M. Neuropathogenesis of AIDS. Mol. Med. Today. 2(1):1996;16-23.
15. Dollard S.C., James H.J., Sharer L.J., Epstein L.G., Gelbard H.A., Dewhurst S. Activation of nuclear factor kappa B in brains from children with HIV-1 encephalitis. Neuropathol. Appl. Neurobiol. 21(6):1995;518-528.
16. Duh E.J., Maury W.J., Folks T.M., Fauci A.S., Rabson A.B. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl. Acad. Sci. U.S.A. 86(15):1989;5974-5978.
17. Eilers A., Whitfield J., Babij C., Rubin L.L., Ham J. Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons. J. Neurosci. 18(5):1998;1713-1724.
18. Fine S.M., Angel R.A., Perry S.W., Epstein L.G., Rothstein J.D., Dewhurst S., Gelbard H.A. Tumor necrosis factor α inhibits glutamate uptake by primary human astrocytes. J. Biol. Chem. 271(26):1996;15303-15306.
19. Gelbard H.A., Dzenko K.A., DiLoreto D., delCerro C., delCerro M., Epstein L.G. Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev. Neurosci. 15:1993;417-422.
20. Gelbard H.A., Nottet H.S.L.M., Swindells S., Jett M., Dzenko K.A., Genis P., White R., Wang L., Choi Y.B., Zhang D., Lipton S.A., Troutellotte W.W., Epstein L.G., Gendelman H.E. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68(7):1994;4628-4635.
21. Genis P., Jett M., Bernton E.W., Gelbard H.A., Dzenko K., Keane R., Resnick L., Volsky D.J., Epstein L.G., Gendelman H.E. Cytokines and arachidonic acid metabolites produced during HIV-infected macrophage-astroglial interactions: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176:1992;1703-1718.
22. Ghosh G., Baltimore D. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature. 344(6267):1990;678-682.
23. Giulian D., Vaca K., Noonan C.A. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science. 250:1990;1593-1596.
24. Glass J.D., Fedor H., Wesselingh S.L., McArthur J.C. Immunocytochemical quantitation for human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38:1995;775-782.
25. Grigoriadis G., Zhan Y., Grumont R.J., Metcalf D., Handman E., Cheers C., Gerondakis S. The REl subunit of NF-κB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO J. 15(24):1996;7099-7107.
26. Grilli M., Pizzi M., Memo M., Spano P.F. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science. 274:1997;1383-1385.
27. Han J., Brown T., Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171(2):1990;465-475.
28. Herbein G., Keshav S., Collin M., Montaner L.J., Gordon S. HIV-1 induces tumour necrosis factor and IL-1 gene expression in primary human macrophages independent of productive infection. Clin. Exp. Immunol. 95:1994;442-449.
29. Hsu H., Xiong J., Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 81:1995;495-504.
30. Ilschner S., Brandt R. The transition of microglia to a ramified phenotype is associated with the formation of stable acetylated and detyrosinated microtubules. Glia. 18:1996;129-140.
31. Koka P., He K., Camerini D., Tran T., Yashar S.S., Merrill J.E. The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor α production in glial cells. J. Neuroimmunol. 57:1995;179-191.
32. Lafrenie R.M., Wahl L.M., Epstein J.S., Hewlett I.K., Yamada K.M., Dhawan S. HIV-1 Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. J. Immunol. 156:1996;1638-1645.
33. Law R.E., Stimmel J.B., Damore M.A., Carter C., Clarke S., Wall R. Lipopolysaccharide-induced NF-κB activation in mouse 70Z/3 Pre-B lymphocytes is inhibited by mevinolin and 5′-methylthioadenosine: roles of protein isoprenylation and carboxyl methylation reactions. Mol. Cell. Biol. 12:1992;103-111.
34. Lee D.H., Goldberg A.L. Selective inhibitors of the proteasome-dependent and vacular pathways of protein degradation in Saccharomyces cerevisiae. J. Biol. Chem. 271(44):1996;27280-27284.
35. Lee S.C., Liu W., Brosnan C.F., Dickson D.W. Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. Lab. Invest. 67(4):1992;465-476.
36. Lee S.C., Liu W., Dickson D.W., Brosnan C.F., Berman J.W. Cytokine production by human fetal microglia and astrocytes. J. Immunol. 150:1993;2659-2666.
37. Lewin S.R., Lambert P., Deacon N.J., Mills J., Crowe S.M. Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages. J. Virol. 71(3):1997;2114-2119.
38. Lipton S.A., Gendelman H.E. Dementia associated with the acquired immunodeficiency syndrome. New Engl. J. Med. 332(14):1995;934-940.
39. Liu W., Brosnan C.F., Dickson D.W., Lee S.C. Macrophage colony-stimulating factor mediates astrocyte-induced microglial ramification in human fetal central nervous system culture. Am. J. Pathol. 145(1):1994;48-53.
40. Merinn A.B., Gabai V.L., Yaglom J., Shifrin V.I., Sherman M.Y. Proteasome inhibitors activate stress kinases and induce HSP72, diverse effects on apoptosis. J. Biol. Chem. 273(11):1998;6373-6379.
41. Merrill J.E., Koyanagi Y., Zack J., Thomas L., Martin F., Chen I.S.Y. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J. Virol. 66(4):1992;2217-2225.
42. Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 16:1983;55.
43. Palombella V.J., Rando O.J., Goldberg A.J., Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell. 78:1994;773-785.
44. Peudenier S., Hery C., Montagnier L., Tardieu M. Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann. Neurol. 29:1991;152-161.
45. Ruvkun G., Finney M. Regulation of transcription and cell identity by POU domain proteins. Cell. 64(3):1991;475-478.
46. Schow S.R., Joly A. N-acetyl-leucinyl-leucinyl-norleucinal inhibits lipopolysaccharide-induced NF-kappaB activation and prevents TNF and IL-6 synthesis in vivo. Cell. Immunol. 175(2):1997;199-202.
47. Selmaj K.W., Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:1988;339-346.
48. Sharer L.R. Pathology of HIV-1 infection of the central nervous system. J. Neuropathol. Exp. Neurol. 51:1992;3-11. (Review).
49. Sharer L.R., Epstein L.G., Cho E.S. Pathologic features of AIDS encephalopathy in children: evidence of LAV/HTLV-II infection of brain. Hum. Pathol. 17:1986;271-284.
50. Sherwood S.W., Kung A.L., Roitelman J., Simoni R.D., Schimke R.T. In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the neutral cysteine protease inhibitor N-acetyl-leucyl-leucyl-norleucinal. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3353-3357.
51. Talley A.K., Dewhurst S., Perry S.W., Dollard S.C., Gummuluru S., Fine S.M., New D., Epstein L.E., Gendelman H.E., Gelbard H.A. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15(5):1995;2359-2366.
52. Traenckner E.B.M., Wilk S., Baeuerle P.A. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 13(22):1994;5331-5433.
53. Trede N.S., Tsytsykova A.V., Chatila T., Goldfeld A.E., Geha R.S. Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: role of NF-kappa B. J. Immunol. 155(2):1995;902-908.
54. Wang C.Y., Mayo M.W., Baldwin A.S. Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kB. Science. 274:1996;784-789.
55. Wesselingh S.L., Power C., Glass J.D. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33:1993;576-582.
56. Yao J., Mackman N., Edgington T.S., Fan S.T. Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells. J. Biol. Chem. 272(28):1997;17795-17801.
57. Yeung M.C., Pulliam L., Lau A.S. The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-α AIDS. 9:1995;137-143.
58. Zheng S., Brown M.C., Taffet S.M. Lipopolysaccharide stimulates both nuclear localization of the nuclear factor kappa B 50-kDa subunit and loss of the 105-kDa precursor in RAW264 macrophage-like cells. J. Biol. Chem. 268(23):1993;17233-17239.